Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 17 submissions in the queue.

Submission Preview

Link to Story

Scientists Partially Restore Vision in Legally Blind People With the Help of CRISPR Gene- Editing -

Accepted submission by upstart at 2021-10-20 12:14:15
News

████ # This file was generated bot-o-matically! Edit at your own risk. ████

Scientists partially restore vision in legally blind people with the help of CRISPR Gene- Editing - OnePexel [onepexel.com]:

Recently Scientists were able to restore vision in legally blind patients through a gene-editing experiment. Many people who were part of this experiment were born with vision issues but are now able to see betterS

Seven patients volunteered for the experiment, wherein doctors modified their DNA by injecting a gene-editing CRISPR directly into the cells. Researchers revealed on Wednesday that patients with leber congenital amaurosis (LCA), a severe form of vision impairment had their vision improved after the gene-editing therapy.

CRISPR hadn’t been used to edit genes like this before. Scientists had earlier used the tool to remove cells from bodies of patients, taking them to the lab for editing, and then infusing the modified cells into patients.

The results of the study was presented by Dr. Mark Pennesi from the Casey Eye Institute at the Oregon Health & Science University at International Symposium on Retinal Degeneration in Nashville, USA. While the treatments appears successful, Pennesi has urged caution while pursuing it on patients. Carlene Knight, one of the subjects of the study told NPR that she is able to view colours brighter and vividly than ever before.

LCA is caused by a genetic mutation that prevents important cells from growing in the retina. Due to this condition, patients begin to experience a progressive loss of vision, after which they become legally blind.

Unlike gene-editing for other diseases, doctors infused the modified gene into the eye directly instead of in a petri dish. Until now, the patients received the CRISPR treatment only in one eye. The treatment will be extended to the other eye if all things go well.

Even then, the treatment did not repair vision for all. Doctors suspect this is due to insufficient dosage or due to too much vision damage. Sure, none of the patients are able to see as fully functional eyes would, but such minor changes are also helping them live fuller lives.


Original Submission